Skip to main content
NCBI home page
Open Veterinary Journal logoLink to Open Veterinary Journal
. 2012 May 13;2(1):46–53.

Role of bovine herpesvirus type 5 (BoHV-5) in diseases of cattle. Recent findings on BoHV-5 association with genital disease

PA Favier 1,2, MS Marin 3,4, SE Pérez 2,3,*
PMCID: PMC4655773  PMID: 26623291

Abstract

Bovine herpesvirus type 5 (BoHV-5) belongs to the family Herpesviridae, subfamily Alphaherpesvirinae, genus Varicellovirus. This virus is a major causative agent of non-suppurative meningoencephalitis in young cattle. It was first isolated in 1962 from a neurological disease outbreak in Australia. BoHV-5 is genetically and antigenically related to bovine herpesvirus type 1 (BoHV-1), a highly prevalent virus responsible for respiratory and genital disease in cattle. Initially, BoHV-5 was considered a subtype of BoHV-1 (BoHV-1.3). However, the exclusive presentation of outbreaks of neurological disease suggested that the virus was a new agent with characteristics of neuropathogenicity. Even though both are neurotropic viruses, only BoHV-5 is capable of replicating extensively in the central nervous system and inducing neurological disease. Occasionally, encephalitis caused by BoHV-1 has been reported. Like other alpha-herpesviruses, BoHV-5 can establish latency in nervous ganglia and, by stress factors or glucocorticoid treatment, latent virus can be reactivated. During episodes of reactivation, the virus is excreted in nasal, ocular and genital secretions and transmitted to other susceptible hosts. Recently, BoHV-5 has been associated with infection of the reproductive tract. The virus has been isolated and the presence of viral DNA has been demonstrated in semen samples from Brazil and Australia and natural transmission of the virus through contaminated semen has also been described. Embryos and oocytes are permissive for BoHV-5 infection and BoHV-5 DNA has been detected in the central nervous system of aborted fetuses. The objective of this review is to compile the limited information on the recent association between BoHV-5 and reproductive disorders in cattle.

Keywords: BoHV-5, Reproductive disorders, Semen

Introduction

Bovine herpesvirus type 5 (BoHV-5) is a major causative agent of non-suppurative meningoencephalitis in young cattle (Magyar et al., 1993; Schwyzer and Ackermann, 1996; Pérez et al., 2002; Delhon et al., 2003; Del Médico Zajac et al., 2010). The virus was first isolated in 1962 from a neurological disease outbreak in Australia (Johnston et al., 1962).

Thereafter, the virus has been sporadically identified in cases of meningoencephalitis in this country (Studdert, 1989; Kirkland et al., 2009), in the United States (d´Offay et al., 1993; Ely et al., 1996) and in Europe (Abdelmagid et al., 1995). However, the disease has a high incidence in South American countries, mainly in Central and Southern Brazil and Argentina (Pérez et al., 2002; Vogel et al., 2003). The reasons for this restricted geographical distribution of neurological cases are unknown.

BoHV-5 is genetically and antigenically related to bovine herpesvirus type 1 (BoHV-1), a virus responsible for a variety of clinical syndromes, including respiratory disease, conjunctivitis, abortion and genital infections (Tikoo et al., 1995; Jones and Chowdhury, 2007).

After natural or experimental infections, alpha-herpesviruses establish latent infections in sensory neurons within trigeminal or dorsal root ganglia (Stevens and Cook, 1971). Viral reactivation from latency can occur naturally, by stress factors, or it can be experimentally induced by glucocorticoid administration. During episodes of reactivation, the virus is re-excreted in nasal, ocular and genital secretions and transmitted to other susceptible hosts (Rock et al., 1992). This is the main mechanism by which alpha-herpesviruses are maintained in nature.

Initially, BoHV-5 was considered a subtype of BoHV-1 (BoHV-1.3) (Engels et al., 1986; Metzler et al., 1986; Studdert, 1989). However, the exclusive presentation of outbreaks of neurological disease suggested that the virus was a new agent with characteristics of neuropathogenicity (Moretti et al., 1964; Watt et al., 1981; Weiblen et al., 1989).

Both BoHV-1 and BoHV-5 are neurotropic viruses (Meyer et al., 2001; Pérez et al., 2002; Varela et al., 2010). Nevertheless, both differ in the ability to cause encephalitis (Ashbaugh et al., 1997). Even though encephalitis caused by BoHV-1 has been reported (Meyer et al., 2001), only BoHV-5 is capable of extensive replication in the central nervous system (CNS) and production of neurological disease (Delhon et al., 2003).

In 1992, the International Committee on Taxonomy of Viruses recognized BoHV-5 as a distinct virus from BoHV-1(Roizman, 1992; Pedraza and Alessi, 2004). The decision was based on the results of restriction site mapping of viral DNA (d´Offay et al., 1993; Whetstone et al., 1993), cross-neutralization studies, and reactivity with monoclonal antibodies (Metzler et al., 1986; Collins et al., 1993).

Presently, strains of BoHV-5 are designated as subtypes “a”, “b” and “non a-non b”, according to restriction endonuclease patterns (D’Arce et al., 2002; Maidana et al., 2011). The transient presence of subtype “b” strains has only been described in Argentina. Nevertheless, in this country, the most common circulating BoHV-5 strains belong to subtype “a” (Maidana et al., 2011).

Further studies are required to classify additional field strains and to compare with the profile of BoHV-5 variants circulating in other countries.

Properties of BoHV-5

BoHV-5 belongs to the family Herpesviridae, subfamily Alphaherpesvirinae, genus Varicellovirus. The virion is enveloped and its diameter can range from 120 to 250 nm, containing an icosahedral nucleocapsid composed by 162 capsomers (Knowles, 2011). The nucleocapsid is surrounded by a proteinaceous layer, called tegument (Thiry et al., 2006).

The genome consists of a single linear molecule of double-stranded DNA and it is classified as a type D genome, which consists of a unique long (UL) and a unique short (US) region, flanked by repeated sequences (Thiry et al., 2006). The genome of BoHV-5 (138, 390 base pairs) is longer than BoHV-1genome and it contains 72 genes (Delhon et al., 2003). Both viruses share 85% genetic similarity (Chowdhury, 1995) and approximately 82% amino acid identity (Delhon et al., 2003).

The lytic replicative cycle of alpha-herpesviruses occurs in a regulated cascade. A virion component activates expression of immediate-early (IE) genes, which have regulatory roles in the activation of early (E) and late (L) genes. In latently infected neurons, the latency-related (LR) gene, a small region of BoHV genome is abundantly transcribed (Rock et al., 1987; Kutish et al., 1990; Schang and Jones, 1997). BoHV-5 -IE proteins (bICP0, bICP4 and bICP22) are the least conserved proteins. The LR gene, which has essential roles in the latency-reactivation cycle of alpha-herpesviruses (Jones, 2003), differs markedly from its BoHV-1 counterpart (Delhon et al., 2003), suggesting that this condition may have important consequences on the in vivo virus pathogenesis.

In cell cultures, BoHV-1 and BoHV-5 share similar morphology and cytopathic effect. Unlike BoHV-1, BoHV-5 is difficult to isolate in cell culture (Carrillo, 1982; Belknap et al., 1994; d´Offay et al., 1995; Ely et al., 1996; Cascio et al., 1999), even from animals experimentally inoculated and showing neurological signs. The difficulty in virus isolation has been related to the low viral titers in tissues samples (Belknap et al., 1994).

Traditionally, BoHV-1 and BoHV-5 are differentiated based on the clinical features of the outbreaks and on DNA restriction profiles after virus isolation (Afonso et al., 2007). More recently, the development of specific PCR techniques has allowed the precise differentiation of both viruses in clinical samples (van Engelenburg et al., 1993, 1995; Chowdhury, 1995; Diallo et al., 2010).

Neurological disease associated with BoHV-5

Outbreaks of meningoencephalitis caused by BoHV-5 are commonly observed in South American countries (Pérez et al., 2002; Vogel et al., 2003). The prevalence of BoHV-5 is presently unknown, mainly because of the serological cross-reactivity with BoHV-1(Vogel et al., 2002; Oldoni et al., 2004; Diel et al., 2007).

The first outbreak of BoHV-5 in Argentina was described in 1982 (Carrillo, 1982). However, in a retrospective study of Argentinean cases with histopathological diagnosis of cerebrocortical necrosis between 1970 and 1999, Pérez et al. (2003) demonstrated by in situ hybridization that BoHV-5 DNA was present in some archival sections of neural tissues. Results from this study confirmed that BoHV-5 was circulating in the country long before the virus was recognized as a causative agent of neurological disorder in cattle.

BoHV-1 pathogenesis has been studied in detail and many aspects can be extrapolated to BoHV-5. The respiratory tract is the main portal of entry of BoHV into the organism. Initial viral replication in the epithelium of the upper respiratory tract and in the tonsils may lead to slight respiratory signs (Meyer et al., 2001; Vogel et al., 2004). Primary replication at the site of entry may last for 15 days (Vogel et al., 2004). In the case of BoHV-5, after replication at mucosal sites, the virus reaches the CNS where viral replication causes neurological damage (Beltrão et al., 2000, Meyer et al., 2001, Pérez et al., 2002).

Two main routes have been described for the access of BoHV-5 to the CNS, 1) via the olfactory tract, through the terminals of the axons that innervate the olfactory mucosa (Nakazato et al., 2000; Pérez et al., 2002) and, 2) via trigeminal nerve, reaching the sensory neurons of trigeminal ganglia where latency is established (Chowdhury et al., 1997; Lee et al., 1999; Coelho and Vidor, 2001; Pérez et al., 2002, 2005).

Unlike BoHV-1, latency of BoHV-5 in other sites of CNS is also possible (Meyer et al., 2001). It has been suggested that viral reactivation from latency may lead to virus spread to different areas of the brain and this would be responsible for the presence of mild neurological signs during episodes of reactivation (Vogel et al., 2003). Neurological signs begin 9 to 10 days post-infection and they include tremors, depression, opistothonus, nystagmus, teeth gridding, circling and recumbency (Carrillo et al., 1983; Beltrão et al., 2000; Meyer et al., 2001, Pérez et al., 2002; Vogel et al., 2003). Signs are progressive and usually fatal (Belknap et al., 1994; Beltrão et al., 2000). BoHV-5 has been considered a classical neurotropic herpesvirus.

However, Schudel et al. (1986) demonstrated that the virus was not restricted to the CNS of animals with clinical signs since the virus was isolated, in parallel, from the respiratory tract. Moreover, in this study, BoHV-5 was recovered from an aborted fetus from a farm in which sporadic cases of abortion were recorded but no cases of neurological disease had been observed. Thus, it is apparent that the virus it not only confined to the respiratory tract and CNS. This is the first presumptive association of BoHV-5 with clinical syndromes different from neurological disease.

Genital disease associated with BoHV-1 and recent findings on reproductive disorders associated with BoHV-5

BoHV-1 isolates are classified into two subtypes; BoHV-1.1, which is mainly responsible for bovine infectious rhinotracheitis, and BoHV-1.2, which is regularly isolated from cases of genital disease (Engels et al., 1986).

The biological differences between subtypes are not clear. Although both subtypes are able to infect the respiratory and genital tracts, it is apparent that each genotype has specific adaptations for growing in particular tissues. Rijsewijk et al. (1999) suggested that differences in glycoprotein C may be responsible for the distinct phenotypes.

Infections of the reproductive tract are usually caused and disseminated by artificial insemination (AI) (Turin et al., 1999). Genital disorders associated with BoHV-1 include pustular balanoposthitis and vulvovaginitis. Balanoposthitis is usually accompanied by a reduction in semen quality (van Oirschot, 1995). It is known that insemination of cows with BoHV-1-contaminated semen can also cause abortion, infertility and endometritis (Elazhary et al., 1980) and it has been demonstrated that the virus dose required to infect the cow via contaminated semen is extremely low, approximately 32 infectious viral particles (Bielanski et al., 1988; Turin et al., 1999). Although abortions might occur as a consequence of genital disease, they are more frequently observed after BoHV-1 respiratory outbreaks (Turin et al., 1999).

In the bull, the virus replicates in the mucosa of the prepuce, penis and urethra after entering the organism via the respiratory or genital tract (van Oirschot, 1995). Contamination of the semen occurs during ejaculation from virus present in the mucosa of the reproductive tract (van Engelenburg et al., 1995). Thus, BoHV-1 DNA is detected in the seminal fluid fraction (van Engelenburg et al., 1993; van Oirschot, 1995).

After genital infection, BoHV-1 establishes latency in sacral ganglia and virus reactivation is a potential source for semen contamination (Ackermann and Wyler, 1984). It is well-established that BoHV-1-latently infected cattle can excrete virus, intermittently, in semen (van Engelenburg et al., 1993, 1995). Therefore, sero-positive bulls should not be allowed in AI centers. Nevertheless, Lemaire et al. (2000) also reported the existence of sero-negative latent carriers, which are an epidemiological threat for AI centers. Furthermore, BoHV-1 is detected in semen during primary infection, before the onset of clinical signs (Weiblen et al., 1992). Therefore, animals without evidence of clinical disease are also a potential source of venereal virus transmission.

Recently, there have been several reports describing the detection of BoHV-5 in bull semen. Gomes et al. (2003) showed that 6 out of 20 (30%) semen samples, previously considered positive for the presence of BoHV-1 were, indeed, BoHV-5-positive, when re-evaluated by a BoHV-5-specific PCR.

In Brazil, a semen sample from an apparently healthy bull, which was identified as BoHV-1-positive during virus surveillance at an AI center in 1996 was re-analyzed by Esteves et al. (2003). In this work, the isolate previously characterized as BoHV-1 was re-classified as BoHV-5. The identity of the virus was determined by the use of BoHV-5-specific monoclonal antibodies in an immunoperoxidase assay and by a gC BoHV-1/5 PCR.

The first evidence of natural transmission of BoHV-5 through contaminated semen was described by Kirkland et al. (2009), in Australia. Later, in the same country, Diallo et al. (2010) isolated the virus from cryopreserved semen of a healthy bull. The identity of the virus was confirmed by PCR and by direct amplicon sequencing, demonstrating the importance of using molecular techniques for the detection of viral agents in semen samples. In Brazil, Oliveira et al. (2011) used a two species-specific nested PCR which differentiates BoHV-1 and BoHV-5 and they identified BoHV-5 DNA in 100% (76/76) semen samples. Additionally, in 44.7% (34/76) samples, BoHV-1 DNA was also present.

Kirkland et al. (2009) described an outbreak of vulvovaginitis with clinical signs and gross lesions identical to those caused by BoHV-1. After virus isolation, BoHV-1 was considered the presumptive causal agent of the genital infection. Later, by restriction enzyme analysis and quantitative PCR it was determined that BoHV-5 was the virus detected in the semen of the bull used for AI. Therefore, it was suggested that BoHV-5 was responsible for the outbreak of vulvovaginitis previously attributed to BoHV-1.

Silva-Frade et al. (2010b) documented the detection of BoHV-5 DNA in the acrosomal region and tail of spermatozoids experimentally exposed to the virus. Nevertheless, it has not been elucidated whether the virus infects the spermatozoid or it is attached to its surface. Among the sperm parameters, the velocity of spermatozoid progression seems to be reduced and a low level of apoptosis, without affecting the total quality of the sperm, has also been reported (Souza et al., 2011). Apparently, unlike BoHV-1 (Tanghe et al., 2005), experimental BoHV-5 infection of spermatozoids does not interfere with in vitro fertilization or embryo development (Souza et al., 2011).

Silva-Frade et al. (2010a) demonstrated that oocytes and embryos were infected by BoHV-5 when experimentally exposed to the virus. By in situ hybridization it was shown that the virus was present in the cumulus cells of the oocytes and in the inner cells of the embryos. BoHV-5 decreased the cleavage rate of oocytes only when they were grown in medium containing fetal bovine serum. However, adverse effects were not observed when polyvinyl alcohol medium was used. Thus, the effect on cleavage rate seems to be dependent on other conditions rather than BoHV-5 infection alone. Viral replication in oocytes and embryos was proved by an increase in virus titers from an inoculation dose of 102.3 TCID50/50μl to 105.3TCID50/50μl at the embryo stage (Silva-Frade et al., 2010b), demonstrating that these cells are permissive for BoHV-5 infection.

Abortions are a common sequel of BoHV-1- respiratory infection. However, the role of BoHV-5 in abortion has not been definitively demonstrated. Recently, in Argentina, Marin et al. (2011) identified BoHV-5 in the CNS of aborted fetuses. Virus isolation from fetal spleen and brain on MDBK cells, a multiplex PCR and seroneutralization tests for BoHV-1 and 5 were carried out. BoHV was not isolated. Nevertheless, BoHV-5 DNA-specific sequences were detected in fetal nervous tissue by multiplex PCR and confirmed by sequencing of PCR products. The presence of BoHV-5 DNA in aborted fetal nervous system is the first description of this virus in association with bovine abortion.

The use of molecular biology techniques for the identification of BoHV-5 in this study was essential to improve the sensitivity of the diagnosis of infectious causes of bovine abortion, especially when autolysis was present. It also allowed the differentiation of the type of BoHV involved. Although virus DNA detection does not prove BoHV-5 is responsible for the abortion, its presence in fetal tissues is suggestive of its involvement.

Many aspects of BoHV-5 association with genital disease remain to be elucidated. It is likely that the pathogenesis of this disorder is similar to that of BoHV-1.

However, further studies are required to establish the role of the virus in the infection of the reproductive tract. Furthermore, other issues need to be addressed. For example, it has not been established whether the infection of a cow with contaminated semen can lead to a latent infection or whether infection by this route can cause neurological disease.

Batches of frozen semen from bulls of accredited AI centers are normally certified negative for acute epidemic diseases.

Presently, an increasing number of these centers are also certified negative for viruses like bovine leukemia virus (BLV), BoHV-1 and bovine viral diarrhea virus (BVDV) (Wrathall et al., 2006). The precise role of BoHV-5 in reproductive disease of cattle is still under study. However, the sole presence of the virus in bovine semen should be considered as a threat for the international trade of frozen semen. As a consequence, detection of BoHV-5 should be included in the pathogen screening policies of AI centers.

Conclusion

For decades, BoHV-5 has been considered a viral agent with exclusive tropism for the CNS. However, recent reports have involved BoHV-5 in the development of genital disease. Presently, the studies on the role of BoHV-5 in diseases of the reproductive tract are not conclusive.

However, there are many evidences that demonstrate that the virus is a potential threat for AI centers since it is excreted in semen and it can be transmitted to susceptible cows. To prevent the spread of the virus by AI, all semen samples, even those of apparently healthy bulls, should be analyzed. Further studies are required to establish the precise role of BoHV-5 in bovine abortion and other conditions of the genital tract.

Furthermore, this review highlights the importance of the application of molecular biology techniques for the characterization and differentiation of bovine herpesviruses in clinical samples.

References

  1. Abdelmagid O.Y, Minocha H.C, Collins J.K, Chowdhury S. I. Fine mapping of bovine herpesvirus-1 (BoHV-1) glycolprotein D (gD) neutralizing epitopes by type-specific monoclonal antibodies and sequence comparison with BoHV-5 gD. Virology. 1995;206:242–253. doi: 10.1016/s0042-6822(95)80039-5. [DOI] [PubMed] [Google Scholar]
  2. Ackermann M, Wyler R. The DNA of an IPV strain of bovid herpesvirus 1 in sacral ganglia during latency after intravaginal infection. Vet. Microbiol. 1984;9:53–63. doi: 10.1016/0378-1135(84)90078-6. [DOI] [PubMed] [Google Scholar]
  3. Afonso D.A, Ortega L.S, Redondo R.A, Trindade Gde S, Barbosa-Stancioli E. F. Characterization of field bovine herpesvirus samples using random amplified polymorphic DNA (RAPD) J. Virol. Method. 2007;140:200–205. doi: 10.1016/j.jviromet.2006.10.010. [DOI] [PubMed] [Google Scholar]
  4. Ashbaugh S.E, Thompson K.E, Belknap E.B, Schultheiss P.C, Chowdhury S, Collins J. K. Specific detection of shedding and latency of bovine herpesvirus 1 and 5 using a nested polymerase chain reaction. J. Vet. Diagn. Invest. 1997;9:387–394. doi: 10.1177/104063879700900408. [DOI] [PubMed] [Google Scholar]
  5. Belknap E.B, Collins J.K, Ayers V.K, Schultheiss P. C. Experimental infection of neonatal calves with neurovirulent bovine herpesvirus type 1.3. Vet. Pathol. 1994;31:358–365. doi: 10.1177/030098589403100309. [DOI] [PubMed] [Google Scholar]
  6. Beltrão N, Flores E.F, Weiblen R, Silva A.M, Roehe P.M, Irigoyen L. F. Infecção e enfermidade neurológica pelo herpesvírus bovino tipo 5 (BHV-5): coelhos como modelo experimental. Pesq. Vet. Bras. 2000;20:144–150. [Google Scholar]
  7. Bielanski A, Loewen K.G, Hare W. C. Inactivation of bovine herpesvirus-1 (BHV-I) from in vitro infected bovine semen. Theriogenology. 1988;30:649–657. doi: 10.1016/0093-691x(88)90300-7. [DOI] [PubMed] [Google Scholar]
  8. Carrillo B.J. Encefalitis en bovinos por “herpesvirus”. Rev. Med. Vet. (Bs. As.) 1982;63(5):372–376. [Google Scholar]
  9. Carrillo B.J, Ambrogi A, Schudel A.A, Vasquez M, Dahme E, Pospichil A. Meningoencephalitis caused by an IBR virus in calves in Argentina. J. Vet. Med. B. 1983;30:327–332. doi: 10.1111/j.1439-0450.1983.tb01852.x. [DOI] [PubMed] [Google Scholar]
  10. Cascio K.E, Belknap E.B, Schultheiss P.C, Ames A.D, Collins J. K. Encephalitis induced by bovine herpesvirus 5 and protection by prior vaccination or infection with bovine herpesvirus 1. J. Vet. Diagn. Invest. 1999;11:134–149. doi: 10.1177/104063879901100205. [DOI] [PubMed] [Google Scholar]
  11. Chowdhury S.I. Molecular basis of antigenic variation between the glycoprotein C of respiratory bovine herpesvirus 1 (BHV-1) and neurovirulent BHV-5. Virology. 1995;213:558–568. doi: 10.1016/s0042-6822(95)80137-5. [DOI] [PubMed] [Google Scholar]
  12. Chowdhury S.I, Lee B.J, Mosier D, Sur J.H, Osorio F. A. Neuropathology of Bovine Herpesvirus type 5 (BHV-5) Meningo-encephalitis in a rabbit seizure model. J. Comp. Pathol. 1997;117:295–310. doi: 10.1016/s0021-9975(97)80078-3. [DOI] [PubMed] [Google Scholar]
  13. Coelho D.H, Vidor T. Infecções por herpesvirus bovino 1 y herpesvirus bovino 5. In: Franklin Riet-Correa, Ana Lucia Schild, María del Carmen Méndez, Ricardo Antonio Amaral Lemos., editors. Doenças de ruminantes e eqüinos. Vol. 1. Livraria Varela: São Paulo; 2001. pp. 97–108. [Google Scholar]
  14. Collins J.K, Ayers V.K, Whetstone C.A, van Drunen Little-van den Hurk S. Antigenic differences between the major glycoproteins of bovine herpesvirus type 1.1 and bovine encephalitis herpesvirus type 1.3. J. Gen. Virol. 1993;74:1509–1517. doi: 10.1099/0022-1317-74-8-1509. [DOI] [PubMed] [Google Scholar]
  15. D’Arce R.C, Almeida R.S, Silva T.C, Franco A.C, Spilki F, Roehe P.M, Arns C. W. Restriction endonuclease and monoclonal antibody analysis of Brazilian isolates of bovine herpesviruses types 1 and 5. Vet. Microbiol. 2002;88:315–324. doi: 10.1016/s0378-1135(02)00126-8. [DOI] [PubMed] [Google Scholar]
  16. Del Médico Zajac M.P, Ladelfa M.F, Kotsias F, Muylkens B, Thiry J, Thiry E, Romera S. A. Biology of bovine herpesvirus 5. Vet. J. 2010;184:138–145. doi: 10.1016/j.tvjl.2009.03.035. [DOI] [PubMed] [Google Scholar]
  17. Delhon G, Moraes M.P, Lu Z, Afonso C.L, Flores E.F, Weiblen R, Kutish G.F, Rock D. L. Genome of bovine herpesvirus 5. J. Virol. 2003;77:10339–10347. doi: 10.1128/JVI.77.19.10339-10347.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Diallo I.S, Hewitson G.R, Hoad J, Turner S, Corney B.G, Rodwell B. J. Isolation of bovine herpesvirus type 5 from the semen of a healthy bull in Australia. Aust. Vet. J. 2010;88:93–95. doi: 10.1111/j.1751-0813.2009.00545.x. [DOI] [PubMed] [Google Scholar]
  19. Diel D.G, Almeida S.R, Brum M.C, Dezengrini R, Weiblen R, Flores E. F. Acute and latent infection by bovine herpesvirus type 5 in experimentally infected goats. Vet. Microbiol. 2007;121(3-4):257–267. doi: 10.1016/j.vetmic.2006.12.019. [DOI] [PubMed] [Google Scholar]
  20. d´Offay J.M, Mock R.E, Fulton R. W. Isolation and characterization of encephalitic bovine herpesvirus type 1 isolates from cattle in North America. J. Vet. Res. 1993;54:534–539. [PubMed] [Google Scholar]
  21. d´Offay J.M, Ely R.W, Baldwin C.A, Whitenack D.L, Stair E.L, Collins J. K. Diagnosis of Encephalitic Bovine Herpesvirus Type 5 (BHV-5) Infection in Cattle: Virus Isolation and Immunohistochemical Detection of Antigen in Formalin-Fixed Bovine Brain Tissues. J. Vet. Diagn. Invest. 1995;7:247–251. doi: 10.1177/104063879500700214. [DOI] [PubMed] [Google Scholar]
  22. Elazhary M.A, Lamothe P, Silim A, Roy R. S. Bovine herpesvirus type 1 in the sperm of a bull from a herd with fertility problems. Can. Vet. J. 1980;21:336–339. [PMC free article] [PubMed] [Google Scholar]
  23. Ely R.W, d´Offay J.M, Ruefer A.H, Cash A. H. Bovine herpesviral encephalitis: a retrospective study on archived formalin-fixed embedded brain tissues. J. Vet. Diagn. Invest. 1996;8:487–492. doi: 10.1177/104063879600800416. [DOI] [PubMed] [Google Scholar]
  24. Engels M, Giuliani C, Wild P, Beck T.M, Loepfe E, Wyler R. The genome of bovine herpesvirus 1 (BHV-1) strains exhibiting a neuropathogenic potential compared to known BHV-1 strains by restriction site mapping and cross-hybridization. Virus Res. 1986;1:57–73. doi: 10.1016/0168-1702(86)90057-2. [DOI] [PubMed] [Google Scholar]
  25. Esteves P.A, Spilki F.R, Franco A.C, Silva T.C, Oliveira E.A, Moojen V, Esmeraldino A.M, Roehe P. M. Bovine herpesvirus type 5 in the semen of a bull not exhibiting clinical signs. Vet. Rec. 2003;152(21):658–659. doi: 10.1136/vr.152.21.658. [DOI] [PubMed] [Google Scholar]
  26. Gomes L.I, Rocha M.A, Souza J.G, Costa E.A, Barbosa-Stancioli E. F. Bovine herpesvirus 5 (BoHV-5) in bull semen: amplification and sequence analysis of the US4 gene. Vet. Res. Commun. 2003;27:495–504. doi: 10.1023/a:1025745825610. [DOI] [PubMed] [Google Scholar]
  27. Johnston L.A.Y, Simmons G.C, McGavin M. D. A viral meningoencephalitis in calves. Aust. Vet. J. 1962;38:207–215. [Google Scholar]
  28. Jones C. Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin. Microbiol. Rev. 2003;16:79–95. doi: 10.1128/CMR.16.1.79-95.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jones C, Chowdhury S. A review of the biology of bovine herpesvirus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines. Anim. Health Res. Rev. 2007;8(2):187–205. doi: 10.1017/S146625230700134X. [DOI] [PubMed] [Google Scholar]
  30. Kirkland P.D, Poynting A.I, Gu X, Davis R. J. Infertility and venereal disease in cattle inseminated with semen containing bovine herpesvirus type 5. Vet. Rec. 2009;165:111–113. doi: 10.1136/vetrec.165.4.111. [DOI] [PubMed] [Google Scholar]
  31. Knowles D. Fenner´s Veterinary Virology. 4th Edition. China: Academic Press; 2011. Herpesvirales; pp. 179–201. [Google Scholar]
  32. Kutish G. F, Mainprize T, Rock D. L. Characterization of the latency-related transcriptionally active region of the bovine herpesvirus 1 genome. J. Virol. 1990;54:5730–5737. doi: 10.1128/jvi.64.12.5730-5737.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lee B.J, Weiss M.L, Moiser B.J, Chowdhury S. I. Spread of bovine herpesvirus type 5 (BHV-5) in rabbit brain after intranasal inoculation. J. Neurovirol. 1999;5:474–484. doi: 10.3109/13550289909045376. [DOI] [PubMed] [Google Scholar]
  34. Lemaire M, Weynants V, Godfroid J, Schynts F, Meyer G, Letesson J.J, Thiry E. Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and virus latency. J. Clin. Microbiol. 2000;38:1885–1894. doi: 10.1128/jcm.38.5.1885-1894.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Magyar G, Tanyi J, Hornyak A, Bartha A. Restriction endonuclease analysis of Hungarian bovine herpesvirus isolates from different clinical forms of IBR, IPV and Encephalitis. Acta Vet. Hung. 1993;41:159–170. [PubMed] [Google Scholar]
  36. Maidana S.S, Ladelfa M.F, Pérez S.E, Lomónaco P.M, Del Médico Zajac M.P, Odeón A, Blanco Viera J, Combessies G, Fondevila N, Palacios M, Thiry J, Muylkens B, Thiry E, Romera S. A. Characterization of BoHV-5 field strains circulation and report of transient specific subtype of bovine herpesvirus 5 in Argentina. BMC Vet. Res. 2011;7:8. doi: 10.1186/1746-6148-7-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Marin M.S, Morrell E.L, Moore D.P, Leunda M.R, Campero C.M, Odeón A. C. In the Proceedings of the 2011 Latin American Buiatric Congress. Paysandú, Uruguay: 2011. Identificación de infecciones duales de Neospora caninum y Herpesvirus bovino tipo 5 mediante PCR en casos de aborto bovino espontáneo. [Google Scholar]
  38. Metzler A.E, Schudel A.A, Engels M. Bovine herpesvirus 1: molecular and antigenic characteristics of variant viruses isolated from calves with neurological disease. Arch. Virol. 1986;87:205–217. doi: 10.1007/BF01315300. [DOI] [PubMed] [Google Scholar]
  39. Meyer G, Lemaire M, Ros C, Belák K, Gabriel A, Cassart D, Coignoul E, Belák S, Thiry E. Comparative pathogenesis of acute and latent infections of calves with bovine herpesvirus type 1 and 5. Arch. Virol. 2001;146:633–652. doi: 10.1007/s007050170136. [DOI] [PubMed] [Google Scholar]
  40. Moretti B, Orfei Z, Mondino G, Persechino A. Infectious bovine rhinotracheitis, clinical observations and isolation of virus. Vet. Ital. 1964;15:676. [PubMed] [Google Scholar]
  41. Nakazato L, Lemos R.A, Riet-Correa F. Polioencefalomalacia em bovinos nos estados de Mato Grosso do Sul e São Paulo. Pesq. Vet. Bras. 2000;20:119–125. [Google Scholar]
  42. Oldoni I, Weiblen R, Inkelmann M.A, Flores E. F. Production and characterization of monoclonal antibodies to a Brazilian bovine herpesvirus type 5. Braz. J. Med. Biol. Res. 2004;37(2):213–221. doi: 10.1590/s0100-879x2004000200008. [DOI] [PubMed] [Google Scholar]
  43. Oliveira M.T, Campos F.S, Dias M.M, Velho F.A, Freneau G.E, Brito W.M, Rijsewijk F.A.M, Franco A.C, Roehe P. M. Detection of bovine herpesvirus 1 and 5 in semen from Brazilian bulls. Theriogenology. 2011;75:1139–1145. doi: 10.1016/j.theriogenology.2010.11.025. [DOI] [PubMed] [Google Scholar]
  44. Pedraza F, Alessi A. Encefalitis bovina por herpesvirus bovino tipo 5 (BoHV-5). Una revisión. Rev. Colomb. Cienc. Pecu. 2004;17:2. [Google Scholar]
  45. Pérez S.E, Bretschneider G, Leunda M.R, Osorio F.A, Flores E.F, Odeón A. C. Primary infection, latency, and reactivation of bovine herpesvirus type 5 in the bovine nervous system. Vet. Pathol. 2002;39:437–444. doi: 10.1354/vp.39-4-437. [DOI] [PubMed] [Google Scholar]
  46. Pérez S, Inman M, Doster A, Jones C. Latency-Related Gene Encoded by Bovine Herpesvirus 1 Promotes Virus Growth and Reactivation from Latency in Tonsils of Infected Calves. J. Clin. Microbiol. 2005;43:393–401. doi: 10.1128/JCM.43.1.393-401.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Pérez S.E, Vagnozzi A, Sur J.H, Odriozola E, Campero C.M, Odeón A. C. Retrospective analysis of cases with diagnosis of cerebrocortical necrosis and its relation with type 5 bovine herpesvirus. Rev. Arg. Microbiol. 2003;35:69–73. [PubMed] [Google Scholar]
  48. Rijsewijk F.A, Kaashoek M.J, Langeveld J.P, Meloen R, Judek J, Bieńkowska-Szewczyk K, Maris-Veldhuis M.A, van Oirschot J. T. Epitopes on glycoprotein C of bovine herpesvirus-1 (BHV-1) that allow differentiation between BHV-1.1 and BHV-1.2 strains. J. Gen. Virol. 1999;80:1477–1483. doi: 10.1099/0022-1317-80-6-1477. [DOI] [PubMed] [Google Scholar]
  49. Rock D. L, Beam S. L, Mayfield J. E. Mapping of bovine herpesvirus type 1 latency-related RNA in trigeminal ganglia of latently infected rabbits. J. Virol. 1987;61:3827–3831. doi: 10.1128/jvi.61.12.3827-3831.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Rock D, Lokensgard J, Lewis T, Kutish G. Characterization of dexamethasone -induced reactivation of latent bovine herpesvirus 1. J. Virol. 1992;66:2484–2490. doi: 10.1128/jvi.66.4.2484-2490.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Roizman B. The family Herpesviridae: An update. Arch. Virol. 1992;123:432–445. doi: 10.1007/BF01317276. [DOI] [PubMed] [Google Scholar]
  52. Schang L, Jones C. Analysis of bovine herpesvirus 1 transcripts during a primary infection of trigeminal ganglia of cattle. J. Virol. 1997;71:6786–6795. doi: 10.1128/jvi.71.9.6786-6795.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Schudel A.A, Carrillo B.J, Wyler R, Metzler A. E. Infections of calves with antigenic variants of bovine herpesvirus 1 (BHV-1) and neurological disease. J. Vet. Med. 1986;33:303–310. doi: 10.1111/j.1439-0450.1986.tb00036.x. [DOI] [PubMed] [Google Scholar]
  54. Schwyzer M, Ackermann M. Molecular virology of ruminant herpesviruses. Vet. Microbiol. 1996;53:17–19. doi: 10.1016/s0378-1135(96)01231-x. [DOI] [PubMed] [Google Scholar]
  55. Silva-Frade C, Martins A, Junior, Borsanelli A.C, Cardoso T. C. Effects of bovine herpesvirus type 5 on development of in vitro produced bovine embryos. Theriogenology. 2010a;73:324–331. doi: 10.1016/j.theriogenology.2009.09.016. [DOI] [PubMed] [Google Scholar]
  56. Silva-Frade C, Gameiro R, Martins A, Junior, Cardoso T. C. Apoptotic and developmental effects of bovine herpesvirus type-5 infection on in vitro-produced bovine embryos. Theriogenology. 2010b;74:1296–1303. doi: 10.1016/j.theriogenology.2010.06.001. [DOI] [PubMed] [Google Scholar]
  57. Souza D.G, Silva-Frade C, Martins A, Jr, Cardoso T. C. Bull semen variables after experimental exposure with Bovine Herpesvirus type 5. Anim. Reprod. Sci. 2011;124:55–60. doi: 10.1016/j.anireprosci.2011.01.004. [DOI] [PubMed] [Google Scholar]
  58. Stevens J.G, Cook M.L. Latent herpes simplex virus in spinal ganglia of mice. Sci. 1971;173:843–845. doi: 10.1126/science.173.3999.843. [DOI] [PubMed] [Google Scholar]
  59. Studdert M.J. Bovine encephalitis herpesvirus. Vet. Rec. 1989;25:584. [PubMed] [Google Scholar]
  60. Tanghe S, Vanroose G, Van Soom A, Duchateau L, Ysebaert M.T, Kerkhofs P, Thiry E, van Drunen Little-van den Hurk S, Van Oostveldt P, Nauwynck H. Inhibition of bovine sperm zona binding by bovine herpesvirus-1. Reprod. Res. 2005;130:251–259. doi: 10.1530/rep.1.00636. [DOI] [PubMed] [Google Scholar]
  61. Thiry J, Keuser V, Muylkens B, Meurens F, Gogev S, Vanderplasschen A, Thiry E. Ruminant alphaherpesviruses related to bovine herpesvirus 1. Vet. Res. 2006;37:169–190. doi: 10.1051/vetres:2005052. [DOI] [PubMed] [Google Scholar]
  62. Tikoo S.K, Campos M, Babiuk L. A. Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Adv. Virus Res. 1995;45:191–223. doi: 10.1016/s0065-3527(08)60061-5. [DOI] [PubMed] [Google Scholar]
  63. Turin L, Russo S, Poli G. BHV-1: New Molecular Approaches to Control a Common and Widespread Infection. Mol. Med. 1999;5:261–284. [PMC free article] [PubMed] [Google Scholar]
  64. van Engelenburg F.A, van Schie F.W, Rijsewijk F.A, van Oirschot J. T. Excretion of bovine herpesvirus 1 in semen is detected much longer by PCR than by virus isolation. J. Clin. Microbiol. 1995;33:308–312. doi: 10.1128/jcm.33.2.308-312.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. van Engelenburg F.A, Maes R.K, van Oirschot J.T, Rijsewijk F. A. Development of a rapid and sensitive polymerase chain reaction assay for detection of bovine herpesvirus type 1 in bovine semen. J. Clin. Microbiol. 1993;31:3129–3135. doi: 10.1128/jcm.31.12.3129-3135.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. van Oirschot J.T. Bovine herpesvirus 1 in semen of bulls and the risk of transmission: a brief review. Vet. Q. 1995;17:29–33. doi: 10.1080/01652176.1995.9694526. [DOI] [PubMed] [Google Scholar]
  67. Varela A.P, Holz C, Cibulski S.P, Teixeira T.E, Antunes A.C, Franco A.C, Roche L.R, Oliveira M.T, Campos F.S, Dezen D, Cenci A, Brito W.D, Roehe P. M. Neutralizing antibodies to bovine herpesvirus types 1 (BoHV-1) and 5 (BoHV-5) and its subtypes. Vet. Microbiol. 2010;142:254–260. doi: 10.1016/j.vetmic.2009.10.016. [DOI] [PubMed] [Google Scholar]
  68. Vogel F.S.F, Lima M, Flores E.F, Weiblen R, Winkelmann E.R, Mayer S.V, Mazzutti K.C, Arenhart S. Replicação e excreção viral durante a infecção aguda e após a reativação da latência induzida por dexametasona em bezerros inoculados com os herpesvírus bovinos tipo 1 (BHV-1) e 5 (BHV-5) Cienc. Rural. 2004;34:1619–1621. [Google Scholar]
  69. Vogel F.S, Caron L, Flores E.F, Weiblen R, Winkelmann E.R, Mayer S.V, Bastos R. G. Distribution of bovine herpesvirus type 5 DNA in the central nervous systems of latently, experimentally infected calves. J. Clin. Microbiol. 2003;41(10):4512–4520. doi: 10.1128/JCM.41.10.4512-4520.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Vogel F, Flores Furtado E, Weiblen R, Kunrath F. C. Atividade neutralizante anti-herpesvírus bovino tipos 1 (BHV-1) e 5 (BHV-5) no soro de bovinos imunizados com vacinas contra o BHV-1. Cienc. Rural. 2002;32:881–883. [Google Scholar]
  71. Watt J.A, Jonston W.S, Mac Leod N.S, Barlow R. M. Infectious bovine rhinotracheitis and encephalitis. Vet. Rec. 1981;108:63. doi: 10.1136/vr.108.3.63. [DOI] [PubMed] [Google Scholar]
  72. Weiblen R, Barros C.S.L, Canabarro T. F. Bovine Meningoencephalitis from IBR vírus. Vet. Rec. 1989;124:666–667. doi: 10.1136/vr.124.25.666-b. [DOI] [PubMed] [Google Scholar]
  73. Weiblen R, Kreutz L.C, Canabarro T.F, Schuch L.F, Rebelatto M.C. Isolation of Bovine Herpesvirus 1 from Preputial Swabs and Semen of Bulls with Balanoposthitis. J. Vet. Diagn. Invest. 1992;4:341–343. doi: 10.1177/104063879200400321. [DOI] [PubMed] [Google Scholar]
  74. Whetstone C.A, Seal B.S, Miller J. M. Variability occurs in the inverted repeat region of genomic DNA from bovine herpesvirus 1 respiratory, genital and bovine herpesvirus 5 encephalitic isolates. Vet. Microbiol. 1993;38:181–189. doi: 10.1016/0378-1135(93)90085-l. [DOI] [PubMed] [Google Scholar]
  75. Wrathall A.E, Simmons H.A, Van Soom A. Evaluation of risks of viral transmission of recipients of bovine embryos arising from fertilization with virus-infected semen. Theriogenology. 2006;65:247–274. doi: 10.1016/j.theriogenology.2005.05.043. [DOI] [PubMed] [Google Scholar]

Articles from Open Veterinary Journal are provided here courtesy of Faculty of Veterinary Medicine, University of Tripoli

RESOURCES